Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleed...

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

World Maternal Antifibrinolytic Trial

First Posted Date
2009-03-31
Last Posted Date
2018-02-26
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
20060
Registration Number
NCT00872469
Locations
🇳🇬

University College Hospital, Ibadan, Nigeria

Dose-ranging Study of Two Doses of Tranexamic Acid During Cardiac Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-12-17
Last Posted Date
2016-09-23
Lead Sponsor
Hopital Foch
Target Recruit Count
600
Registration Number
NCT00809393
Locations
🇫🇷

department of anesthesiology, Bichat Hospital, Paris, France

🇫🇷

department of anaesthesiology, CHU Jean Minjoz, Besancon, France

🇫🇷

Hopital Foch, Suresnes, France

and more 1 locations

Tranexamic Acid for Preventing Progressive Intracranial Haemorrhage in Traumatic Brain Injury

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-09-18
Last Posted Date
2013-11-25
Lead Sponsor
Khon Kaen University
Target Recruit Count
238
Registration Number
NCT00755209
Locations
🇹🇭

Khon Kaen Regional hospital, Muang district, Khon Kaen, Thailand

Tranexamic Acid in Surgery of Advanced Ovarian Cancer

First Posted Date
2008-08-22
Last Posted Date
2022-03-15
Lead Sponsor
Preben Kjolhede, MD, professor
Target Recruit Count
100
Registration Number
NCT00740116
Locations
🇸🇪

Department of Obstetrics and Gynecology, Kalmar Central Hospital, Kalmar, Sweden

🇸🇪

Dept of Obstetric and Gynecology, Ryhov Central Hospital, Jönköping, Sweden

🇸🇪

University Hospital, Department of Obsterics and Gynecology,, Linköping, Sweden

Tranexamic Acid for Craniofacial Surgery

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2008-07-25
Last Posted Date
2017-02-15
Lead Sponsor
University of Pittsburgh
Target Recruit Count
20
Registration Number
NCT00722436
Locations
🇺🇸

The Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

The Effect of Tranexamic Acid on Intraoperative and Post-Operative Bleeding in Functional Endoscopic Sinus Surgery

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2008-05-05
Last Posted Date
2010-09-03
Lead Sponsor
University of Calgary
Target Recruit Count
74
Registration Number
NCT00671281
Locations
🇨🇦

Rockyview General Hospital, Calgary, Alberta, Canada

Tranexamic Acid in Urologic Surgery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2008-05-01
Last Posted Date
2014-04-07
Lead Sponsor
Università Vita-Salute San Raffaele
Registration Number
NCT00670345
Locations
🇮🇹

Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia, Milano, Italy

A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-01-08
Last Posted Date
2009-11-10
Lead Sponsor
Mayo Clinic
Target Recruit Count
20
Registration Number
NCT00588133

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)

First Posted Date
2007-07-13
Last Posted Date
2021-06-09
Lead Sponsor
Shire
Target Recruit Count
85
Registration Number
NCT00500656
Locations
🇮🇹

Università degli Studi di Milano, Dipartimento di Medicina Interna, Milano, Italy

Safety of Tranexamic Acid in Reducing Bleeding in Adults Undergoing Spinal Surgery

Phase 3
Completed
Conditions
Interventions
First Posted Date
2007-03-07
Last Posted Date
2007-11-30
Lead Sponsor
University Health Network, Toronto
Target Recruit Count
151
Registration Number
NCT00444470
Locations
🇨🇦

Trillium Health Centre, Mississauga, Ontario, Canada

🇨🇦

Department of Anesthesia and Orthopedics; Toronto Western Hospital, Toronto, Ontario, Canada

🇨🇦

St. Michael's Hospital, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath